These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
264 related articles for article (PubMed ID: 32218664)
1. A systematic review and network meta-analysis of adjuvant therapy for curatively resected biliary tract cancers. Kish M; Chan K; Perry K; Ko YJ Curr Oncol; 2020 Feb; 27(1):e20-e26. PubMed ID: 32218664 [TBL] [Abstract][Full Text] [Related]
2. Individual patient data meta-analysis of adjuvant gemcitabine-based chemotherapy for biliary tract cancer: combined analysis of the BCAT and PRODIGE-12 studies. Edeline J; Hirano S; Bertaut A; Konishi M; Benabdelghani M; Uesaka K; Watelet J; Ohtsuka M; Hammel P; Kaneoka Y; Joly JP; Yamamoto M; Monard L; Ambo Y; Louvet C; Ando M; Malka D; Nagino M; Phelip JM; Ebata T Eur J Cancer; 2022 Mar; 164():80-87. PubMed ID: 35182925 [TBL] [Abstract][Full Text] [Related]
3. Gemcitabine and Oxaliplatin Chemotherapy or Surveillance in Resected Biliary Tract Cancer (PRODIGE 12-ACCORD 18-UNICANCER GI): A Randomized Phase III Study. Edeline J; Benabdelghani M; Bertaut A; Watelet J; Hammel P; Joly JP; Boudjema K; Fartoux L; Bouhier-Leporrier K; Jouve JL; Faroux R; Guerin-Meyer V; Kurtz JE; Assénat E; Seitz JF; Baumgaertner I; Tougeron D; de la Fouchardière C; Lombard-Bohas C; Boucher E; Stanbury T; Louvet C; Malka D; Phelip JM J Clin Oncol; 2019 Mar; 37(8):658-667. PubMed ID: 30707660 [TBL] [Abstract][Full Text] [Related]
4. Current standards and future perspectives in adjuvant treatment for biliary tract cancers. Lamarca A; Edeline J; McNamara MG; Hubner RA; Nagino M; Bridgewater J; Primrose J; Valle JW Cancer Treat Rev; 2020 Mar; 84():101936. PubMed ID: 31986437 [TBL] [Abstract][Full Text] [Related]
5. Network meta-analysis of adjuvant chemotherapy in biliary tract cancers: Setting the scene for new randomized evidence. Salani F; Vetere G; Rossini D; Genovesi V; Carullo M; Bartalini L; Massa V; Bernardini L; Caccese M; Cesario S; Graziani J; Grelli G; Mangogna F; Vivaldi C; Masi G; Fornaro L Liver Int; 2024 Oct; 44(10):2763-2772. PubMed ID: 39072988 [TBL] [Abstract][Full Text] [Related]
6. Pitfalls, challenges, and updates in adjuvant systemic treatment for resected biliary tract cancer. Rizzo A; Brandi G Expert Rev Gastroenterol Hepatol; 2021 May; 15(5):547-554. PubMed ID: 33571059 [No Abstract] [Full Text] [Related]
7. BILCAP trial and adjuvant capecitabine in resectable biliary tract cancer: reflections on a standard of care. Rizzo A; Brandi G Expert Rev Gastroenterol Hepatol; 2021 May; 15(5):483-485. PubMed ID: 33307876 [TBL] [Abstract][Full Text] [Related]
8. Adjuvant chemotherapy in biliary tract cancer: state of the art and future perspectives. Akhoundova Sanoyan D; McNamara MG; Lamarca A; Valle JW Curr Opin Oncol; 2020 Jul; 32(4):364-369. PubMed ID: 32541326 [TBL] [Abstract][Full Text] [Related]
9. Capecitabine plus oxaliplatin versus gemcitabine plus oxaliplatin as first-line therapy for advanced biliary tract cancers: a multicenter, open-label, randomized, phase III, noninferiority trial. Kim ST; Kang JH; Lee J; Lee HW; Oh SY; Jang JS; Lee MA; Sohn BS; Yoon SY; Choi HJ; Hong JH; Kim MJ; Kim S; Park YS; Park JO; Lim HY Ann Oncol; 2019 May; 30(5):788-795. PubMed ID: 30785198 [TBL] [Abstract][Full Text] [Related]
10. Comparison of the effects of adjuvant concurrent chemoradiotherapy and chemotherapy for resected biliary tract cancer. Kim H; Heo MH; Kim JY BMC Gastroenterol; 2020 Jan; 20(1):20. PubMed ID: 31992208 [TBL] [Abstract][Full Text] [Related]
12. [Adjuvant treatment of biliary tract cancers: Who and how?]. Edeline J Bull Cancer; 2020 Jan; 107(1):48-53. PubMed ID: 31980143 [TBL] [Abstract][Full Text] [Related]
13. Advances in the treatment of biliary tract cancers. Uson Junior PLS; Bogenberger J; Borad MJ Curr Opin Gastroenterol; 2020 Mar; 36(2):85-89. PubMed ID: 31972599 [TBL] [Abstract][Full Text] [Related]
14. Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study. Primrose JN; Fox RP; Palmer DH; Malik HZ; Prasad R; Mirza D; Anthony A; Corrie P; Falk S; Finch-Jones M; Wasan H; Ross P; Wall L; Wadsley J; Evans JTR; Stocken D; Praseedom R; Ma YT; Davidson B; Neoptolemos JP; Iveson T; Raftery J; Zhu S; Cunningham D; Garden OJ; Stubbs C; Valle JW; Bridgewater J; Lancet Oncol; 2019 May; 20(5):663-673. PubMed ID: 30922733 [TBL] [Abstract][Full Text] [Related]
15. Long-Term Outcomes and Exploratory Analyses of the Randomized Phase III BILCAP Study. Bridgewater J; Fletcher P; Palmer DH; Malik HZ; Prasad R; Mirza D; Anthony A; Corrie P; Falk S; Finch-Jones M; Wasan H; Ross P; Wall L; Wadsley J; Evans TR; Stocken D; Stubbs C; Praseedom R; Ma YT; Davidson B; Neoptolemos J; Iveson T; Cunningham D; Garden OJ; Valle JW; Primrose J; J Clin Oncol; 2022 Jun; 40(18):2048-2057. PubMed ID: 35316080 [TBL] [Abstract][Full Text] [Related]
16. Advances in adjuvant therapy of biliary tract cancer: an overview of current clinical evidence based on phase II and III trials. Belkouz A; Wilmink JW; Haj Mohammad N; Hagendoorn J; de Vos-Geelen J; Dejong CHC; Homs MYV; Groot Koerkamp B; van Gulik TM; van Oijen MGH; Punt CJA; Klümpen H Crit Rev Oncol Hematol; 2020 Jul; 151():102975. PubMed ID: 32464483 [TBL] [Abstract][Full Text] [Related]
17. Adjuvant and neoadjuvant therapy for biliary tract cancer: a review of clinical trials. Nara S; Esaki M; Ban D; Takamoto T; Shimada K; Ioka T; Okusaka T; Ishii H; Furuse J Jpn J Clin Oncol; 2020 Dec; 50(12):1353-1363. PubMed ID: 33037430 [TBL] [Abstract][Full Text] [Related]
18. A systematic review and network meta-analysis of phase III randomised controlled trials for adjuvant therapy following resection of pancreatic ductal adenocarcinoma (PDAC). Kamarajah SK; Bundred JR; Alrawashdeh W; Manas D; White SA HPB (Oxford); 2020 May; 22(5):649-659. PubMed ID: 31894014 [TBL] [Abstract][Full Text] [Related]
19. Systematic review with network meta-analysis: adjuvant therapy for resected biliary tract cancer. Zhu GQ; Shi KQ; You J; Zou H; Lin YQ; Wang LR; Braddock M; Chen YP; Zheng MH Aliment Pharmacol Ther; 2014 Oct; 40(7):759-70. PubMed ID: 25099956 [TBL] [Abstract][Full Text] [Related]
20. Clinical efficacy of adjuvant treatments for patients with resected biliary tract cancer: a systematic review and network meta-analysis. Chen Y; Zhang B; Liu C; Cao Y; Lyu C; Qiu M BMJ Open; 2022 Apr; 12(4):e051421. PubMed ID: 35440445 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]